- Home
- PRKS vs VCEL Comparison
PRKS vs VCEL Comparison
Compare PRKS & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- VCEL
- Stock Information
- Founded
- PRKS 1959
- VCEL 1989
- Country
- PRKS United States
- VCEL United States
- Employees
- PRKS N/A
- VCEL N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRKS Health Care
- VCEL Health Care
- Exchange
- PRKS Nasdaq
- VCEL Nasdaq
- Market Cap
- PRKS 2.4B
- VCEL 2.1B
- IPO Year
- PRKS 2013
- VCEL 1997
- Fundamental
- Price
- PRKS $48.89
- VCEL $41.83
- Analyst Decision
- PRKS Buy
- VCEL Strong Buy
- Analyst Count
- PRKS 13
- VCEL 8
- Target Price
- PRKS $57.85
- VCEL $62.00
- AVG Volume (30 Days)
- PRKS 679.8K
- VCEL 439.0K
- Earning Date
- PRKS 08-06-2025
- VCEL 07-31-2025
- Dividend Yield
- PRKS N/A
- VCEL N/A
- EPS Growth
- PRKS 3.53
- VCEL 521.85
- EPS
- PRKS 3.85
- VCEL 0.05
- Revenue
- PRKS $1,714,827,000.00
- VCEL $238,541,000.00
- Revenue This Year
- PRKS $2.47
- VCEL $23.03
- Revenue Next Year
- PRKS $2.32
- VCEL $24.52
- P/E Ratio
- PRKS $12.29
- VCEL $724.21
- Revenue Growth
- PRKS N/A
- VCEL 14.80
- 52 Week Low
- PRKS $37.68
- VCEL $37.39
- 52 Week High
- PRKS $60.83
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- PRKS 65.62
- VCEL 47.28
- Support Level
- PRKS $44.61
- VCEL $40.53
- Resistance Level
- PRKS $46.43
- VCEL $43.57
- Average True Range (ATR)
- PRKS 1.29
- VCEL 1.67
- MACD
- PRKS 0.65
- VCEL -0.10
- Stochastic Oscillator
- PRKS 97.96
- VCEL 27.68
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.